Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
System disruptions
There are recurring service disruptions on some of the search portals due to high traffic. We are working to resolve the issue, you may temporarily encounter an error message.
Change search
Link to record
Permanent link

Direct link
Publications (10 of 29) Show all publications
Ancillotti, M., Andersson, D. I. & Sandegren, L. (2026). When Does Evidence Create a Moral Obligation to Depart from Antibiotic Guidelines?. American Journal of Bioethics, 26(9), 109-111
Open this publication in new window or tab >>When Does Evidence Create a Moral Obligation to Depart from Antibiotic Guidelines?
2026 (English)In: American Journal of Bioethics, ISSN 1526-5161, E-ISSN 1536-0075, Vol. 26, no 9, p. 109-111Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
Taylor & Francis, 2026
National Category
Medical Ethics
Identifiers
urn:nbn:se:uu:diva-596871 (URN)10.1080/15265161.2026.2709544 (DOI)001862628200001 ()2-s2.0-105048708931 (Scopus ID)
Funder
Swedish Research Council, 2024-06125
Available from: 2026-08-28 Created: 2026-08-28 Last updated: 2026-09-18Bibliographically approved
Nordvall, A.-C., Ancillotti, M., Oljans, E. & Nilsson, E. (2025). Antimicrobial resistance and the non-accountability effect on consumers’ behaviou. Social Responsibility Journal, 21(5), 1125-1143
Open this publication in new window or tab >>Antimicrobial resistance and the non-accountability effect on consumers’ behaviou
2025 (English)In: Social Responsibility Journal, ISSN 1747-1117, E-ISSN 1758-857X, Vol. 21, no 5, p. 1125-1143Article in journal (Refereed) Published
Abstract [en]

Purpose

A status quo situation has occurred among actors, policymakers, producers, retailers and consumers where no one takes the lead on the antimicrobial resistance (AMR) fight. Common theoretical approaches to behaviour including awareness, understanding and use are insufficient in the AMR context. In this paper, the authors suggest the application of accountability literature to fully understand the status quo situation with AMR.

Design/methodology/approach

AMR in food has become an alarming problem in the past decade and is an increasing threat to global health. The knowledge about AMR often comes from a medical context where the perspective is completely different. Therefore, it is difficult for consumers to apply this to a grocery store context purchasing food.

Findings

This paper uses the concept of accountability and the significant other within the accountability field and discusses how this could help overcome the non-action state of mind of consumers and other actors.

Practical implications

Enhanced accountability could significantly improve One-Health solutions for combating AMR. By fostering a culture of shared responsibility and transparent communication among stakeholders, the silo effect may be mitigated, promoting collaborative efforts. Accountability mechanisms should ensure that roles and responsibilities are clearly defined and communicated across sectors, such as health care, agriculture and policymaking. Educational initiatives can increase AMR awareness, enabling stakeholders to make informed decisions. Integrating perspectives from various domains will facilitate the development of holistic strategies, thus improving the overall effectiveness of efforts to address AMR and ensuring a sustainable approach to public health.

Social implications

Enhanced accountability in AMR management can lead to significant social benefits. By promoting transparency and collective responsibility, communities can foster greater trust and cooperation among various stakeholders, including health-care providers, policymakers and consumers. Increased awareness of AMR can empower individuals to make informed decisions, thereby promoting public health and safety. Socially, this could lead to more sustainable practices in antibiotic use and a reduction in the spread of resistant infections. In addition, fostering a culture of accountability ensures that efforts to combat AMR are more inclusive, equitable and effective, ultimately benefiting society as a whole.

Originality/value

The proposal to create strategies according to a basis of accountability can be applied at all levels of the AMR problem and for all actors. This therefore provides important knowledge about how AMR can be approached in a more long-term way where initiatives to prevent the spread of AMR do not take place in parallel or become difficult to access.

Place, publisher, year, edition, pages
Emerald Group Publishing Limited, 2025
Keywords
Antimicrobial resistance, behaviour change, Sustainable consumer behaviour, Sustainable health, Accountability
National Category
Economics and Business
Identifiers
urn:nbn:se:uu:diva-552073 (URN)10.1108/srj-12-2023-0721 (DOI)001438656200001 ()2-s2.0-105001065037 (Scopus ID)
Available from: 2025-03-07 Created: 2025-03-07 Last updated: 2025-06-18Bibliographically approved
Venant Samwel, E., Biasiotto, R., Mosha, M. & Ancillotti, M. (2025). Beyond symbolic participation: youth-led organisations' voices and actions against antimicrobial resistance in Africa South of the Sahara. Global Health Action, 18(1), Article ID 2601409.
Open this publication in new window or tab >>Beyond symbolic participation: youth-led organisations' voices and actions against antimicrobial resistance in Africa South of the Sahara
2025 (English)In: Global Health Action, ISSN 1654-9716, E-ISSN 1654-9880, Vol. 18, no 1, article id 2601409Article in journal (Refereed) Published
Abstract [en]

Background

Antimicrobial resistance (AMR) is a global health threat, disproportionately affecting Africa South of the Sahara, where young people have been identified as key stakeholders in AMR prevention and awareness; however, effective engagement beyond symbolic participation remains challenging, limiting the impact of youth-led initiatives in addressing AMR in the region.ObjectivesTo examine how youth-led actors in Africa South of the Sahara engage in AMR awareness, education and advocacy; the challenges they encounter; and the institutional conditions needed to move beyond symbolic participation.

Methods

A qualitative study design was employed, involving semi-structured interviews with young professionals engaged in AMR efforts across Africa South of the Sahara. Participants were recruited through convenience and snowball sampling. Online interviews were conducted between March and September 2023. Data were analysed using reflexive thematic analysis.

Results

Seventeen participants (age range 22–34) from 15 countries shared insights on AMR awareness, community engagement, and barriers in their work. Major findings included the perception of AMR as an invisible threat, generational and structural challenges in community outreach, and the need for financial and institutional support. Despite these obstacles, participants demonstrated innovative approaches, including adapting AMR outreach methods to specific social groups and a strong commitment to AMR education and policy advocacy.

Conclusions

Findings underscore the essential role of youth in AMR efforts in Africa South of the Sahara and the need for greater institutional support and capacity-building. Enhancing youth involvement beyond symbolic roles is crucial to advancing AMR initiatives, particularly through tailored communication strategies and collaborative policymaking.

Place, publisher, year, edition, pages
Taylor & Francis, 2025
Keywords
antimicrobial resistance; youth engagement; sub-Saharan Africa; policy; qualitative research
National Category
Public Health, Global Health and Social Medicine
Identifiers
urn:nbn:se:uu:diva-575531 (URN)10.1080/16549716.2025.2601409 (DOI)001645420200001 ()41424330 (PubMedID)2-s2.0-105025378594 (Scopus ID)
Available from: 2026-01-12 Created: 2026-01-12 Last updated: 2026-01-14Bibliographically approved
Nordvall, A.-C., Nilsson, E., Oljans, E. & Ancillotti, M. (2025). Beyond the blame game: fostering consumer engagement in addressing antimicrobial resistance. Future Microbiology, 20(11), 711-714
Open this publication in new window or tab >>Beyond the blame game: fostering consumer engagement in addressing antimicrobial resistance
2025 (English)In: Future Microbiology, ISSN 1746-0913, E-ISSN 1746-0921, Vol. 20, no 11, p. 711-714Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
Taylor & Francis, 2025
Keywords
Antimicrobial resistance, consumer behaviour, gamification, one health, teaching
National Category
Business Administration
Identifiers
urn:nbn:se:uu:diva-564248 (URN)10.1080/17460913.2025.2528405 (DOI)001522254900001 ()40605623 (PubMedID)2-s2.0-105010135249 (Scopus ID)
Available from: 2025-07-31 Created: 2025-07-31 Last updated: 2026-01-23Bibliographically approved
Nilsson, E., Oljans, E., Nordvall, A.-C. & Ancillotti, M. (2025). Communicating Antimicrobial Resistance on Instagram: Content Analysis of #AntibioticResistance. JMIR Infodemiology, 5, Article ID e67825.
Open this publication in new window or tab >>Communicating Antimicrobial Resistance on Instagram: Content Analysis of #AntibioticResistance
2025 (English)In: JMIR Infodemiology, E-ISSN 2564-1891, Vol. 5, article id e67825Article in journal (Refereed) Published
Abstract [en]

Background: Antimicrobial resistance (AMR) is a major global health issue heavily influenced by human behavior. Effective communication and awareness-raising are crucial in curbing AMR, with social network sites (SNSs) significantly shaping health behaviors. Despite their potential, current analyses of AMR on SNSs have focused mainly on top-down communication initiatives.

Objective: This study aims to examine AMR on Instagram (Meta Platforms), identifying key actors, content themes, and the nature of the communication to understand how AMR is portrayed and perceived.

Methods: Based on the sender-message-channel-receiver model, this study used content analysis to review publicly accessible posts on Instagram. The data refer to 24 months, focusing on the hashtag “#antibioticresistance.” After cleaning the data, 610 posts (10% of the total 6105) were analyzed.

Results: Content creators were predominantly information drivers or professionals in science and health. Posts frequently featured text-dominated visuals or images of bacteria and laboratory tests. However, the AMR posts were found to be siloed, with limited engagement beyond specific interest groups. The study highlighted the neutrality and accuracy of the content but noted the challenge of reaching a broader audience.

Conclusions: While Instagram serves as a platform for accurate and informative AMR communication, the post of it remains confined to niche groups, limiting its broader impact. To enhance engagement, AMR discussions should be integrated into more general interest content, use visually compelling formats, and encourage institutional participation and interactive user engagement.

Place, publisher, year, edition, pages
JMIR Publications, 2025
Keywords
antimicrobial resistance, social, media engagement, communication, Instagram, health communication, content analysis
National Category
Public Health, Global Health and Social Medicine
Identifiers
urn:nbn:se:uu:diva-566978 (URN)10.2196/67825 (DOI)001556049200001 ()40834419 (PubMedID)
Note

All authors contributed equally

Available from: 2025-09-10 Created: 2025-09-10 Last updated: 2025-09-10Bibliographically approved
Ancillotti, M., Grauman, Å., Veldwijk, J., Flobak, Å. & Mascalzoni, D. (2025). Exploring doctors’ perspectives on precision medicine and AI in colorectal cancer: opportunities and challenges for the doctor-patient relationship. BMC Medical Informatics and Decision Making, 25(1), Article ID 283.
Open this publication in new window or tab >>Exploring doctors’ perspectives on precision medicine and AI in colorectal cancer: opportunities and challenges for the doctor-patient relationship
Show others...
2025 (English)In: BMC Medical Informatics and Decision Making, E-ISSN 1472-6947, Vol. 25, no 1, article id 283Article in journal (Refereed) Published
Abstract [en]

Background

Precision medicine and artificial intelligence (AI) are increasingly integrated into colorectal cancer (CRC) care, offering personalised treatment strategies and data-driven decision support. While these technologies promise improved outcomes, they also raise challenges concerning clinical decision-making, the doctor-patient relationship, and ethics. This study explores physicians’ perspectives on integrating precision medicine and AI in CRC care.

Methods

A qualitative study was conducted using semi-structured interviews with ten CRC physicians from six European countries. Participants were recruited through purposive and snowball sampling. Interviews were analysed using thematic analysis.

Results

Three key themes emerged from the analysis. First, physicians described precision medicine as a logical extension of existing tailoring practices, offering new opportunities while introducing complexity. Many expressed concerns about the blurred boundary between experimental and standard treatments, noting potential implications for equity and ethical decision-making. Second, AI was viewed as a future partner in care, with the potential to enhance efficiency and assist in synthesising complex data. However, participants voiced concerns about trust, clinical responsibility, and the lack of regulatory clarity, particularly due to AI’s “black box” nature. Finally, doctors reported challenges in communicating both precision medicine and AI-based recommendations to patients. They emphasised the importance of adapting communication strategies to individual patients and highlighted the need for structured approaches to ensure patient understanding and prevent miscommunication, especially when dealing with uncertain outcomes or emerging technologies.

Conclusions

The findings highlight both the opportunities and challenges of integrating precision medicine and AI in CRC care. Addressing concerns related to communication, ethics, and regulation requires clear guidance and improved support for clinicians. Precision medicine and AI enhance CRC care but demand robust communication, regulation, and ethical safeguards to ensure transparency, trust, and physician autonomy.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2025
Keywords
Precision medicine, Artificial intelligence, Colorectal cancer, Doctor-patient relationship, Clinical decision-making, Medical ethics
National Category
Cancer and Oncology Public Health, Global Health and Social Medicine Medical Ethics
Identifiers
urn:nbn:se:uu:diva-564245 (URN)10.1186/s12911-025-03134-0 (DOI)001540023800001 ()40739240 (PubMedID)2-s2.0-105012179742 (Scopus ID)
Available from: 2025-07-31 Created: 2025-07-31 Last updated: 2025-08-20Bibliographically approved
Ancillotti, M., Conticelli, E., Tondelli, S. & Mascalzoni, D. (2025). Framing exposure to excessive and improper lighting as light-public health. Discover Public Health, 22(1), Article ID 429.
Open this publication in new window or tab >>Framing exposure to excessive and improper lighting as light-public health
2025 (English)In: Discover Public Health, E-ISSN 3005-0774, Vol. 22, no 1, article id 429Article in journal (Refereed) Published
Abstract [en]

Excessive or improper lighting can affect human health and well-being. However,lighting is seldom considered within frameworks analyzing the interrelationsbetween the urban environment and the health and well-being of communities.Lighting-related concerns are often conceptualized and discussed in environmentalterms through the light pollution frame. Positively, this frame emphasizes humanresponsibility for the environmental detriment and animal harm caused by lightingand promotes the discussion of aesthetics and existential dimensions connected tonocturnal darkness. Negatively, it is flawed with epistemological shortcomings andnormativity; it is prone to the risk of ideological and political polarisation and tendsto underemphasize the health implications of excessive and improper lighting. Thisstudy addresses this gap by arguing for the advantages of a public health framing oflighting-related concerns. In particular, it highlights how this perspective can bettercapture the health implications of lighting and inform urban policies. Placing lightconcerns within a public health framework entails presenting a relatively knownlandscape that resonates with the value systems of virtually everyone. This approachsupports the creation of a common, multi-stakeholder space in discussions onlighting policies, balancing considerations of urban security, safety, inclusivity, andaccessibility as different dimensions of diverse populations’ health and well-being.By emphasizing the public health dimension, this study contributes to the discourseon lighting as a determinant of health and well-being. Such a holistic frameworkaligns with the United Nations Sustainable Development Goal 3 on good health andwell-being by fostering conditions that advance health for all, addressing lighting notmerely as an environmental issue but as a critical public health priority.

Place, publisher, year, edition, pages
Springer Nature, 2025
Keywords
ALAN, Lighting, Public health, Light pollution
National Category
Public Health, Global Health and Social Medicine Occupational Health and Environmental Health
Identifiers
urn:nbn:se:uu:diva-564246 (URN)10.1186/s12982-025-00765-6 (DOI)001536630100001 ()2-s2.0-105011937214 (Scopus ID)
Funder
EU, Horizon 2020, 945238
Available from: 2025-07-31 Created: 2025-07-31 Last updated: 2025-08-14Bibliographically approved
Martin, S., Ancillotti, M., Slokenberga, S. & Matar, A. (2024). A comparative ethical analysis of the Egyptian clinical research law. BMC Medical Ethics, 25(1), Article ID 48.
Open this publication in new window or tab >>A comparative ethical analysis of the Egyptian clinical research law
2024 (English)In: BMC Medical Ethics, E-ISSN 1472-6939, Vol. 25, no 1, article id 48Article in journal (Refereed) Published
Abstract [en]

Background

In this study, we examined the ethical implications of Egypt’s new clinical trial law, employing the ethical framework proposed by Emanuel et al. and comparing it to various national and supranational laws. This analysis is crucial as Egypt, considered a high-growth pharmaceutical market, has become an attractive location for clinical trials, offering insights into the ethical implementation of bioethical regulations in a large population country with a robust healthcare infrastructure and predominantly treatment-naïve patients.

Methods

We conducted a comparative analysis of Egyptian law with regulations from Sweden and France, including the EU Clinical Trials Regulation, considering ethical human subject research criteria, and used a directed approach to qualitative content analysis to examine the laws and regulations. This study involved extensive peer scrutiny, frequent debriefing sessions, and collaboration with legal experts with relevant international legal expertise to ensure rigorous analysis and interpretation of the laws.

Results

On the rating of the seven different principles (social and scientific values, scientific validity, fair selection of participants, risk-benefit ratio, independent review, informed consent and respect for participants) Egypt, France, and EU regulations had comparable scores. Specific principles (Social Value, Scientific Value, and Fair selection of participants) were challenging to directly identify due to certain regulations embodying 'implicit' principles more than explicitly stated ones.

Conclusion

The analysis underscores Egypt's alignment with internationally recognized ethical principles, as outlined by Emanuel et al., through its comparison with French, Swedish, and EU regulations, emphasizing the critical need for Egypt to continuously refine its ethical regulations to safeguard participant protection and research integrity. Key issues identified include the necessity to clarify and standardize the concept of social value in research, alongside concerns regarding the expertise and impartiality of ethical review boards, pointing towards a broader agenda for enhancing research ethics in Egypt and beyond.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2024
Keywords
Biomedical laws, Ethical principles, Egypt, Clinical trials, Social value
National Category
Medical Ethics
Research subject
Ethics
Identifiers
urn:nbn:se:uu:diva-527433 (URN)10.1186/s12910-024-01040-0 (DOI)001210808900001 ()38689214 (PubMedID)
Funder
Uppsala University
Available from: 2024-05-01 Created: 2024-05-01 Last updated: 2024-07-04Bibliographically approved
Grauman, Å., Ancillotti, M., Veldwijk, J. & Mascalzoni, D. (2023). Precision cancer medicine and the doctor-patient relationship: a systematic review and narrative synthesis. BMC Medical Informatics and Decision Making, 23(1), Article ID 286.
Open this publication in new window or tab >>Precision cancer medicine and the doctor-patient relationship: a systematic review and narrative synthesis
2023 (English)In: BMC Medical Informatics and Decision Making, E-ISSN 1472-6947, Vol. 23, no 1, article id 286Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: The implementation of precision medicine is likely to have a huge impact on clinical cancer care, while the doctor-patient relationship is a crucial aspect of cancer care that needs to be preserved. This systematic review aimed to map out perceptions and concerns regarding how the implementation of precision medicine will impact the doctor-patient relationship in cancer care so that threats against the doctor-patient relationship can be addressed.

METHODS: Electronic databases (Pubmed, Scopus, Web of Science, Social Science Premium Collection) were searched for articles published from January 2010 to December 2021, including qualitative, quantitative, and theoretical methods. Two reviewers completed title and abstract screening, full-text screening, and data extraction. Findings were summarized and explained using narrative synthesis.

RESULTS: Four themes were generated from the included articles (n = 35). Providing information addresses issues of information transmission and needs, and of complex concepts such as genetics and uncertainty. Making decisions in a trustful relationship addresses opacity issues, the role of trust, and and physicians' attitude towards the role of precision medicine tools in decision-making. Managing negative reactions of non-eligible patients addresses patients' unmet expectations of precision medicine. Conflicting roles in the blurry line between clinic and research addresses issues stemming from physicians' double role as doctors and researchers.

CONCLUSIONS: Many findings have previously been addressed in doctor-patient communication and clinical genetics. However, precision medicine adds complexity to these fields and further emphasizes the importance of clear communication on specific themes like the distinction between genomic and gene expression and patients' expectations about access, eligibility, effectiveness, and side effects of targeted therapies.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2023
Keywords
Cancer, Communication, Doctor-patient relation, Narrative synthesis, Oncology, Precision medicine, Shared-decision making, Systematic review
National Category
Cancer and Oncology Medical Ethics
Research subject
Bioethics
Identifiers
urn:nbn:se:uu:diva-518530 (URN)10.1186/s12911-023-02395-x (DOI)001127329000003 ()38098034 (PubMedID)
Funder
Uppsala University
Available from: 2023-12-20 Created: 2023-12-20 Last updated: 2024-01-23Bibliographically approved
Ancillotti, M., Huls, S. P. I., Krockow, E. M. & Veldwijk, J. (2023). Prosocial Behaviour and Antibiotic Resistance: Evidence from a Discrete Choice Experiment. Patient, 17(2), 191-202
Open this publication in new window or tab >>Prosocial Behaviour and Antibiotic Resistance: Evidence from a Discrete Choice Experiment
2023 (English)In: Patient, ISSN 1178-1653, E-ISSN 1178-1661, Vol. 17, no 2, p. 191-202Article in journal (Refereed) Published
Abstract [en]

Introduction

The health of a community depends on the health of its individuals; therefore, individual health behaviour can implicitly affect the health of the entire community. This is particularly evident in the case of infectious diseases. Because the level of prosociality in a community might determine the effectiveness of health programmes, prosocial behaviour may be a crucial disease-control resource. This study aimed to extend the literature on prosociality and investigate the role of altruism in antibiotic decision making.

Methods

A discrete choice experiment was conducted to assess the influence of altruism on the general public’s preferences regarding antibiotic treatment options. The survey was completed by 378 Swedes. Latent class analysis models were used to estimate antibiotic treatment characteristics and preference heterogeneity. A three-class model resulted in the best model fit, and altruism significantly impacted preference heterogeneity.

Results

Our findings suggest that people with higher altruism levels had more pronounced preferences for treatment options with lower contributions to antibiotic resistance and a lower likelihood of treatment failure. Furthermore, altruism was statistically significantly associated with sex, education, and health literacy.

Conclusions

Antibiotic awareness, trust in healthcare systems, and non-discriminatory priority setting appear to be structural elements conducive to judicious and prosocial antibiotic behaviour. This study suggests that prosocial messages could help to decrease the demand for antibiotic treatments.

Place, publisher, year, edition, pages
Springer, 2023
Keywords
Prosocial behavior, prosociality, altruism, antibiotic resistance, antimicrobial resistance, Sweden
National Category
Public Health, Global Health and Social Medicine Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
urn:nbn:se:uu:diva-526780 (URN)10.1007/s40271-023-00666-3 (DOI)001127333800001 ()38117400 (PubMedID)
Funder
Uppsala University
Available from: 2024-04-18 Created: 2024-04-18 Last updated: 2025-02-20Bibliographically approved
Projects
Countering the spread of AMR via consumer behaviour – Playing the AMR card [2024-06118_VR]; Uppsala University; Publications
Nordvall, A.-C., Nilsson, E., Oljans, E. & Ancillotti, M. (2025). Beyond the blame game: fostering consumer engagement in addressing antimicrobial resistance. Future Microbiology, 20(11), 711-714
Humanities and social sciences in One Health: Promoting just and responsible antibiotic behaviour in society [2024-06125_VR]; Uppsala University; Publications
Ancillotti, M., Andersson, D. I. & Sandegren, L. (2026). When Does Evidence Create a Moral Obligation to Depart from Antibiotic Guidelines?. American Journal of Bioethics, 26(9), 109-111
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0001-5748-0672

Search in DiVA

Show all publications